Cannabis Bioscience International Holdings, Inc. (CBIH)
↓ Download CSV- Sector Services
- Incorporated CO
- Fiscal year ends May 31
In fiscal 2025, Cannabis Bioscience International Holdings, Inc. reported revenue of $303.0K, up 21.8% from the prior year. The company ran a net loss, with a net margin of -181.1% and a gross margin of 86.8%. It held $31.9K in total assets against $1.20M in total liabilities.
Key ratios (FY2025)
86.8%
Gross margin
-139.1%
Operating margin
-181.1%
Net margin
+21.8%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $303.0K | $248.8K | $316.8K | — |
| Cost of Revenue | $40.1K | $45.6K | $93.5K | — |
| Gross Profit | $262.9K | $203.2K | $223.4K | — |
| Operating Income | -$421.4K | -$486.1K | -$983.4K | — |
| Net Income | -$548.8K | -$651.3K | -$1.03M | — |
| EPS (Diluted) | $-0.00 | $-0.00 | $-0.00 | — |
| Total Assets | $31.9K | $57.2K | $43.4K | — |
| Total Liabilities | $1.20M | $1.14M | $635.0K | — |
| Shareholders' Equity | -$1.16M | -$1.08M | -$591.7K | -$361.1K |
| Operating Cash Flow | -$329.6K | -$479.4K | -$898.4K | — |
| Shares Outstanding | 11.63B | 10.43B | 10.06B | — |